Tim Coughlin
Vermogen: 3 M $ op 30-06-2026
Vermogen: 3 M $ op 30-06-2026
Timothy P.
Coughlin is Chairman at aTyr Pharma, Inc. since 2024.
He is a Non-Executive Director at ADC Therapeutics SA starting in 2025.
He serves as an Independent Director at Travere Therapeutics, Inc. since 2015.
He is a Director at Vir Biotechnology, Inc. beginning in 2026.
Former roles include Independent Director at Fate Therapeutics, Inc. from 2015 to 2025, Director at Peloton Therapeutics, Inc. in 2019, Senior Manager-Health Sciences Practice at Ernst & Young LLP from 1989 to 1999, Chief Financial Officer at Neurocrine Biosciences, Inc., and Vice President-Financial Services at CommonSpirit Health from 1999 to 2002.
Education includes a graduate degree from San Diego State University conferred in 2002 and an undergraduate degree from Temple University (Pennsylvania) conferred in 1989.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-06-2026 | 56.250 ( 0,06% ) | 3 M $ | 30-06-2026 | |
ADC THERAPEUTICS LTD 0,06% | 03-06-2026 | 72.400 ( 0,06% ) | 77 468 $ | 30-06-2026 |
ATYR PHARMA, INC. 0,06% | 11-05-2026 | 56.000 ( 0,06% ) | 33 432 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Directeur/Bestuurslid | 31-03-2015 |
| ATYR PHARMA, INC. | Voorzitter | 14-03-2024 |
| ADC THERAPEUTICS SA | Directeur/Bestuurslid | 01-06-2025 |
| VIR BIOTECHNOLOGY, INC. | Directeur/Bestuurslid | 09-06-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| FATE THERAPEUTICS, INC. | Directeur/Bestuurslid | 29-05-2025 |
| PELOTON THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-12-2019 |
CommonSpirit Health (Illinois)
CommonSpirit Health (Illinois) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit catholic health organization | Financieel Directeur/CFO | 01-01-2002 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01-01-1999 |
| NEUROCRINE BIOSCIENCES, INC. | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Peloton Therapeutics, Inc.
Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
CommonSpirit Health (Illinois)
CommonSpirit Health (Illinois) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit catholic health organization | Commercial Services |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
ADC Therapeutics SA
ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau